Markus Reindl Selected Research

Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)

9/2020	Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
9/2020	Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
1/2020	Recent developments in MOG-IgG associated neurological disorders.
10/2017	Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.
3/2017	Methodological Challenges in Protein Microarray and Immunohistochemistry for the Discovery of Novel Autoantibodies in Paediatric Acute Disseminated Encephalomyelitis.
1/2017	Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?
1/2017	Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.
12/2016	Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
6/2015	Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
12/2013	Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in children.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Reindl Research Topics

Disease

55	Multiple Sclerosis 01/2022 - 10/2002
42	Neuromyelitis Optica (Devic's Disease) 05/2021 - 11/2009
30	Demyelinating Diseases (Demyelinating Disease) 12/2021 - 11/2006
26	Optic Neuritis (Retrobulbar Neuritis) 05/2021 - 09/2011
20	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 07/2008
13	Myelitis 01/2021 - 05/2010
13	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 09/2020 - 03/2011
11	Multiple System Atrophy 01/2020 - 08/2003
10	Inflammation (Inflammations) 11/2021 - 08/2004
8	Transverse Myelitis (Necrotizing Myelitis) 01/2021 - 09/2011
7	Autoimmune Diseases of the Nervous System 11/2021 - 04/2016
7	Disease Progression 08/2021 - 10/2005
7	Nervous System Diseases (Neurological Disorders) 12/2020 - 12/2003
7	Encephalomyelitis (Myeloencephalitis) 09/2020 - 04/2015
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 08/2003
7	Neuroinflammatory Diseases 01/2020 - 11/2007
5	Parkinson Disease (Parkinson's Disease) 01/2020 - 08/2003
5	Central Nervous System Diseases (CNS Diseases) 01/2020 - 10/2013
4	COVID-19 01/2022 - 01/2021
4	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 01/2016
4	Infections 01/2021 - 12/2004
4	Parkinsonian Disorders (Parkinsonism) 01/2020 - 03/2005
4	Leukocytosis (Pleocytosis) 11/2016 - 06/2013
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2016 - 11/2009
4	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2009 - 07/2004
4	Malaria 12/2009 - 07/2004
3	Ganglion Cysts (Ganglion) 05/2021 - 11/2016
3	Measles 09/2020 - 04/2015
3	Rubella (German Measles) 09/2020 - 04/2015
3	Herpes Zoster 09/2020 - 04/2015
3	Synucleinopathies 01/2020 - 08/2011
3	Relapsing-Remitting Multiple Sclerosis 01/2015 - 02/2009
3	Friedreich Ataxia (Friedreich's Ataxia) 08/2012 - 08/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2011 - 05/2010
3	Guillain-Barre Syndrome 10/2011 - 06/2008
3	Atherosclerosis 07/2008 - 07/2002
2	Gliosis 01/2020 - 03/2013
2	Stroke (Strokes) 01/2020 - 10/2011
2	Seizures (Absence Seizure) 01/2020 - 10/2015
2	Glioma (Gliomas) 10/2016 - 01/2008
2	Ataxia (Dyssynergia) 12/2011 - 08/2011
2	Communicable Diseases (Infectious Diseases) 10/2011 - 12/2009
2	Cerebral Malaria 12/2009 - 02/2009
2	Cerebellar Ataxia (Dysmetria) 09/2005 - 03/2005
2	Striatonigral Degeneration 03/2005 - 08/2003
1	Atrophy 05/2021
1	Varicella Zoster Virus Infection 01/2021
1	Teratoma (Teratoid Tumor) 01/2021

Drug/Important Bio-Agent (IBA)

63	AntibodiesIBA 01/2022 - 07/2003
48	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 10/2002
33	Immunoglobulin G (IgG)IBA 05/2021 - 06/2008
29	AutoantibodiesIBA 01/2021 - 12/2003
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2003
8	Oligoclonal BandsIBA 09/2020 - 06/2013
7	AntigensIBA 09/2020 - 06/2003
7	CytokinesIBA 01/2020 - 08/2003
7	Complement System Proteins (Complement)IBA 01/2020 - 07/2011
7	Aquaporin 4IBA 01/2020 - 12/2013
5	Immunoglobulin M (IgM)IBA 09/2020 - 12/2003
5	Aquaporins (Water Channels)IBA 01/2020 - 12/2011
5	EnzymesIBA 01/2019 - 07/2004
5	ImmunosorbentsIBA 01/2019 - 07/2004
4	AutoantigensIBA 11/2021 - 01/2007
4	Retinaldehyde (Retinal)IBA 05/2021 - 01/2016
4	Peptides (Polypeptides)IBA 01/2021 - 10/2015
4	ChemokinesIBA 01/2020 - 07/2008
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 01/2015
4	alpha-SynucleinIBA 11/2007 - 08/2003
3	Rituximab (Mabthera)FDA Link 08/2021 - 05/2013
3	Immunoglobulin IsotypesIBA 09/2020 - 01/2010
3	AlbuminsIBA 09/2020 - 10/2011
3	SynucleinsIBA 01/2020 - 01/2013
3	anti-aquaporin 4 autoantibodyIBA 01/2020 - 09/2011
3	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 11/2009
3	EpitopesIBA 10/2013 - 06/2003
3	FrataxinIBA 08/2012 - 08/2011
3	Mitochondrial Proteins (Mitochondrial Protein)IBA 08/2012 - 08/2011
3	Erythropoietin FDA Link 08/2012 - 08/2011
2	Biological ProductsIBA 01/2021 - 01/2010
2	Protein Isoforms (Isoforms)IBA 01/2021 - 05/2010
2	Lactic Acid (Lactate)FDA LinkGeneric 09/2020 - 09/2020
2	Immunoglobulin A (IgA)IBA 09/2020 - 09/2020
2	SteroidsIBA 11/2016 - 08/2015
2	Glatiramer Acetate (Copaxone)FDA Link 10/2015 - 02/2009
2	Nerve Growth Factor (NGF)IBA 05/2013 - 08/2004
2	Pharmaceutical PreparationsIBA 08/2011 - 02/2009
2	Levodopa (L Dopa)FDA LinkGeneric 05/2009 - 09/2005
2	Matrix Metalloproteinases (MMPs)IBA 07/2008 - 06/2008
2	Therapeutic UsesIBA 08/2007 - 11/2006
2	3-nitropropionic acidIBA 03/2005 - 08/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004 - 08/2003
2	Myelin Basic ProteinIBA 07/2003 - 10/2002
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Cell Surface ReceptorsIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021

Therapy/Procedure

10	Therapeutics 01/2021 - 07/2004
3	Immunotherapy 01/2020 - 03/2014